Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole Long-acting Injection in the Spanish Clinical Practice: a Retrospective, Observational Study
Phase of Trial: Phase IV
Latest Information Update: 27 Aug 2018
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms PROSIGO
- Sponsors Otsuka Pharmaceutical
- 20 Aug 2018 Status changed from recruiting to completed.
- 17 May 2018 Planned End Date changed from 1 Mar 2018 to 31 Jul 2018.
- 17 May 2018 Planned primary completion date changed from 1 Mar 2018 to 31 Jul 2018.